Publications
Publications
- September 1999 (Revised September 2005)
- HBS Case Collection
Strategic Deal Making at Millennium Pharmaceuticals
Abstract
A small start-up in 1993, Millennium Pharmaceuticals was a name-brand biotechnology company by the end of 1998, with a market capitalization of $1.4 billion. The Cambridge-based company's growth strategy had relied heavily on building alliances for early-stage drug discovery and licensing its gene-based technology.
Keywords
Citation
Watkins, Michael D., and Sarah Matthews. "Strategic Deal Making at Millennium Pharmaceuticals." Harvard Business School Case 800-032, September 1999. (Revised September 2005.)